| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.25 | 2e-05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |